Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Share News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Byotrol's bumper interim revenues

Tue, 17th Nov 2009 14:37

Anti-microbial technology developer Byotrol reported strong revenue growth in the six months to September 2009 but this rate of growth will be difficult to maintain. Revenues jumped from £388,000 to £2m - more than double the level for the previous 12 months. Publicity about swine flu and other infections has undoubtedly helped and there was one big order from distributor Bunzl for the food sector. The timing of orders is difficult to predict. House broker Charles Stanley is sticking to its full year revenue forecast of £2.7m until there is more indication of second half trading levels. The interim loss was reduced from £1.46m to £590,000. The higher revenues led to an increased working capital requirement. There is still £1.68m in the bank after a £1.19m cash outflow. The working capital should partly unwind in the second half but a further cash outflow is expected. Byotrol hopes that its deal with Synergy Healthcare, which has taken a long time to generate serious sales, is finally getting into gear. Synergy has the distribution rights to Byotrol products in UK hospitals and has been slow off the mark in exploiting them. The latest deal is with Boots which will increase the credibility of the Byotrol brand. This will also help to get the Byotrol name into the minds of consumers although other parts of the business have much more long-term potential.
More News
25 Jun 2014 12:40

UK MIDDAY BRIEFING: AbbVie Sets Out Case For Shire Acquisition

Read more
25 Jun 2014 11:44

UK WINNERS & LOSERS: REIT's Rise On Carney Message, Sector Activity

Read more
25 Jun 2014 09:54

Byotrol Narrows Annual Loss And Raises GBP1.3M In New Equity

Read more
18 Mar 2014 12:02

Byotrol To Meet Expectations, Finance Director And Chairman Depart

LONDON (Alliance News) - Microbial technology products company Byotrol PLC Tuesday announced several changes to its board, and said that it expects revenue and earnings before interest, tax, depreciation and amortisation to be in line with market expectations for its full-year. Finance Dire

Read more
18 Mar 2014 08:27

UK MORNING BRIEFING: ASOS Shares Drop 20% On Sales Update

LONDON (Alliance News) - Shares have opened lower Tuesday amid continued concern about Ukraine and some negative statements from UK companies.

AIM is suffering the most, as its largest stock ASOS is down 20% despite reporting total retail sales rose by 26% in the tw

Read more
19 Nov 2013 14:50

Byotrol Benefits From Business Integration As Loss Narrows

Read more
19 Nov 2013 08:07

AIM IN BRIEF: Centamin Further Reduces Stake In Nyota Minerals

Read more
9 Oct 2013 08:33

Byotrol Appoints David Traynor As Chief Executive

Read more
3 Oct 2013 11:39

UK WINNERS & LOSERS: Phorm Jumps; Supermarkets Rebound

Read more
3 Oct 2013 09:33

Byotrol buys out rest of Byotrol Consumer Products

Byotrol, which develops anti-microbial hygiene technologies, has agreed to buy out the rest of Byotrol Consumer Products (BCP). The company will acquire all the remaining assets it does not already own in the joint venture with What If! Innovation Capital Nominees. Byotrol will pay a consideration

Read more
3 Oct 2013 08:15

Byotrol To Acquire Remaining Shares In Joint Venture, Byotrol Consumer Products

Read more
8 Feb 2013 08:31

Byotrol full year revenues to disappoint as deal is signed with M&S

Byotrol, a company which develops anti-microbial hygiene technologies, disappointed investors with the news that although revenue for the year ending March 31st 2013 will be above that of the previous year, it will be lower than previously anticipated. This was because sales of the group's UltraPr

Read more
16 Aug 2012 16:29

Byotrol Chairman makes double purchase following 'landmark agreement'

Ralph Kugler, the non-Executive Chairman of Byotrol, an anti-micorbial hygiene firm, has made a double purchase of shares in the same week the company made the announcement of a 'landmark agreement' with Kimberly-Clark Corporation. 56-year-old Kugler purchased 150,000 shares on Wednesday at 7.5p e

Read more
13 Aug 2012 13:18

Small caps round-up: Minera IRL, Environmental Recycling, Byotrol

Shares in Latin America-focused gold miner Minera IRL fell on Monday after the group announced that revenues and profits in the second quarter slipped year-on-year on the back of a decline in production due to anticipated lower grades. Gold sales of 6,889 ounces were ahead of management's expectat

Read more
19 Jul 2012 12:07

Small caps round-up: Byotrol, sareum, KDD ...

Byotrol, an anti-microbial hygiene company, has continued to make progress and has maintained the momentum seen in the second half of last year into the current financial year. The balance sheet continues to remain strong and is well positioned to its objective of positive cash generation at the ear

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.